To counter the accumulation of DNA damage, eukaryotic cells employ an intricate network of pathways that promote damage recognition, checkpoint signaling, and DNA repair. Components of the damage response network have been linked to various genetic disorders that are typified by hypersensitivity to DNA damaging agents and cancer predisposition. In particular, the tumor suppressor BRCA1 has been described as a master regulator of genome stability due to its involvement in various aspects of the damage response. Despite BRCA1's established role in the development of breast and ovarian cancers, a molecular understanding of its functions remains limited. We recently showed that Xenopus egg extracts recapitulate BRCA1 functions observed in human and mouse models, providing a soluble, highly amenable system for future mechanistic studies. Initially, we will focus on BRCA1's newly described role in dismantling the replicative helicase after it collides with a DNA crosslink. Unloading the CMG helicase complex (comprised of Cdc45, MCM2-7, and GINS) is required to access and repair the underlying lesion, suggesting that helicase eviction may be a fundamental mechanism of DNA damage tolerance. We will also identify how BRCA1's functions are connected to cellular sensitivity, enabling us to devise and test new strategies for improved crosslink-based therapeutics. Going forward, we will extend our analysis to additional BRCA1 functions to establish a comprehensive understanding of BRCA1's many roles in DNA repair and tumor suppression.

Public Health Relevance

BRCA1 is a well-established tumor suppressor gene that is frequently mutated in hereditary breast and ovarian cancers. BRCA1 plays a central role in regulating how cells respond to various types of DNA damage and is critical to promote error-free repair. Understanding the mechanism of BRCA1-mediated repair will provide important insights into how cancer cells develop and respond to specific chemotherapeutic treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Unknown (R35)
Project #
1R35GM119512-01
Application #
9140641
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Willis, Kristine Amalee
Project Start
2016-09-01
Project End
2021-05-31
Budget Start
2016-09-01
Budget End
2017-05-31
Support Year
1
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Biochemistry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Rycenga, Halley B; Long, David T (2018) The evolving role of DNA inter-strand crosslinks in chemotherapy. Curr Opin Pharmacol 41:20-26
Fullbright, George; Rycenga, Halley B; Gruber, Jordon D et al. (2016) p97 Promotes a Conserved Mechanism of Helicase Unloading during DNA Cross-Link Repair. Mol Cell Biol 36:2983-2994